|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$7,293
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$3,600
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$7,538
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$12,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$29,093
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$30,150
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$156,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
4R01CA166264-04
|
$307,872
|
$307,872
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
4P50CA094056-16
|
$1,286,033
|
$77,162
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$9,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$326,212
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
|
5R21CA198776-02
|
$168,563
|
$168,563
|
CHOI, SUNG
|
UNIVERSITY OF MICHIGAN
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
4R01CA044722-26
|
$203,601
|
$203,601
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
2R44CA153474-02A1
|
$472,008
|
$472,008
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
1K07CA204201-01
|
$176,652
|
$176,652
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
1R01CA184456-01A1
|
$341,981
|
$112,854
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
4P01CA154291-05
|
$2,641,256
|
$264,126
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$393,241
|
$393,241
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$393,241
|
$196,620
|
Hodge, James
|
CCR (NCI)
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$3,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$128,655
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
|
4R01CA166084-04
|
$318,652
|
$159,326
|
HERSHMAN, DAWN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-03
|
$402,343
|
$402,343
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using FAP to Selectively Target Epithelial Cancers
|
4R01CA163930-05
|
$349,435
|
$174,718
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Using EMP2 for Image Guided Drug Delivery for Breast Cancer
|
4R01CA163971-05
|
$319,550
|
$319,550
|
WADEHRA, MADHURI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-03
|
$488,805
|
$488,805
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
4R01CA172921-04
|
$357,673
|
$178,837
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
4R01CA102792-14
|
$335,140
|
$335,140
|
BOOTHMAN, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$317,745
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$3,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$1,875
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-14S1
|
$72,364
|
$11,578
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
4U54CA096300-14
|
$931,644
|
$149,063
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
|
1R21CA202488-01A1
|
$200,318
|
$200,318
|
SWORDS, RONAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$13,892
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$34,953
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
$434,694
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
$90,391
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
$4,999
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
$8,009
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S1
|
$60,000
|
$5,400
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S2
|
$125,000
|
$11,250
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S3
|
$246,015
|
$22,141
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S4
|
$96,787
|
$8,711
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S5
|
$199,999
|
$18,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
4P30CA177558-04
|
$2,107,000
|
$189,630
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S1
|
$115,495
|
$5,775
|
RAMOS, JOE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S2
|
$200,000
|
$10,000
|
RAMOS, JOE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
4P30CA071789-17
|
$1,913,800
|
$95,690
|
RAMOS, JOE
|
UNIVERSITY OF HAWAII AT MANOA
|
Total relevant funding to Chemotherapy for this search: $289,467,872
|